Articles
Follicle Thought is pleased to share an exclusive interview with the CEO of OrganTech as we draw closer to 2024. OrganTech Inc. Resurgence Prior to the year 2020, one researcher’s name was held synonymously with the topic of hair cloning by online hair-seeking communities – Dr. Takashi Tsuji, and most often, just “Tsuji.” The…
Read More
TrichoSeeds有限公司福田Junji创立的生物技术PhD, has announced a timeline for the start of its hair cloning clinical trial. Note, the snippet above taken from the ko-karie.com website has been edited since the publishing of this article. Luckily, we caught a screenshot of it before the change was made. The…
Read More
Follicle Thought presents an exclusive interview with Epibiotech CEO Dr. Jong-Hyuk Sung to discuss EPI-001 trials, other alopecia pipeline candidates, and the company’s latest business developments. Epibiotech’s therapeutic pipeline, displayed above, represents the most diverse pipeline for hair loss or alopecia-related therapies in the world. In fact, Epibiotech is one of the only biotech companies…
Read More
China Trial Enrolls 180 Patients To Complete Enrollment: Update (8/22/23) On August 22, 2023, Kintor Pharmaceutical announced the completion of patient enrollment in a phase 2 trial in China for GT20029. This means all of the patients needed to complete the study have been enrolled, and will undergo their dosing schedule over the next 12…
Read More
Seeking Scarless Hair Transplants With Donor Regeneration On July 11th, 2023, Dr. Blake Bloxham completed a verteporfin trial in his New York office. The trial focused on testing verteporfin’s effect on minimizing scarring or potentially producing scarless healing during a hair transplant procedure. Dr. Bloxham treated three different patients undergoing FUT (Follicular Unit Transplantation) hair…
Read More
A Pennsylvania-based biotech is seeking to reinvent one of the most discussed mainstream hair growth procedures, platelet rich plasma therapy. Carmell Therapeutics Plasma-based Bioactive Material It’s a thought that has crossed the minds of many people who have heard of, or received, PRP injections for hair growth – “can’t they make a version of PRP…
Read More
Published on: Oct 7, 2020 at 20:04
Read More
The German biotech startup Mallia Therapeutics (formerly MalliaBiotech) has secured seed funding to further its hair loss drug soluble CD83. CD83 Hair Growth Through Immune Modulation On July 11, 2023, Mallia Therapeutics issued a press release announcing a successful seed financing round and the presentation of data at a European Hair Research Society (EHRS) meeting.…
Read More
Life Code shares poster from the 25th World Congress of Dermatology Singapore 2023 with Follicle Thought. Artificial Intelligence Small Molecule Enhanced Hair Growth Follicle Thought is pleased to share an exclusive look at Life Code’s poster from the current World Congress of Dermatology event. Just over a year ago, I shared an introduction to Life…
Read More
On June 28, 2023, Amplifica Holdings Group announced the initiation of a clinical trial for one of its lead candidate molecules from the study of hairy moles. Amplifica’s AMP-303 has officially entered a clinical trial. According to a news release on the company’s website and PR Newswire, the first patient was dosed in a multicenter,…
Read More